Toward a more complete appreciation of the clinical spectrum of Borrelia burgdorferi infection: Early lyme disease without erythema migrans

American Journal of Medicine

Volumn 114, Issue 1, 2003, Pages 74-75

  Sigal, Leonard H ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VACCINE;

ANTIGEN ANTIBODY COMPLEX; ARTHRALGIA; ARTHRITIS; ASEPTIC MENINGITIS; BABESIA MICROTI; BORRELIA BURGDORFERI; BORRELIA INFECTION; CARDITIS; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; CRANIAL NEUROPATHY; DIAGNOSTIC ERROR; DISEASE COURSE; EHRLICHIA; ERYTHEMA CHRONICUM MIGRANS; FACIAL NERVE PARALYSIS; FATIGUE; FIBROMYALGIA; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; IXODES SCAPULARIS; LYME DISEASE; MUSCLE STIFFNESS; NECK MUSCLE; PERIPHERAL NEUROPATHY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SEROCONVERSION; SEROLOGY; SHORT SURVEY; SKIN INFLAMMATION; SLEEP DISORDER; SPIROCHETE; SYMPTOM; TICK BORNE DISEASE; VACCINATION; VIRUS INFECTION; WESTERN BLOTTING;

EID: 0037249193     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(02)01439-0     Document Type: Editorial

References (17)

1. Steere A.C. Lyme disease. N Engl J Med. 345:2001;115-125.
2. Weinstein A., Britchkov M. Lyme arthritis and post-Lyme disease syndrome. Curr Opin Rheumatol. 14:2002;383-387.
3. Klempner M.S., Hu L.T., Evans J., et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 345:2001;85-92.
4. Kalish R.A., Japlan R.F., Taylor E., et al. Evaluation of study patients with Lyme disease, 10-20 year follow-up. J Infect Dis. 183:2001;453-460.
5. Belongia E.A., Reed K.D., Mitchell P.A., et al. Tickborne infections as a cause of nonspecific febrile illness in Wisconsin. Clin Infect Dis. 32:2001;1434-1439.
6. Ruebush T.K.D., Juranek D.D., Chisholm E.S., et al. Human babesiosis on Nantucket Island. Evidence for self-limited and subclinical infections. N Engl J Med. 297:1977;825-827.
7. Aguero-Rosenfeld M.E., Horowitz H.W., Bittker S., et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 125:1996;904-908.
8. O'Connor C.R., Sigal L.H., Callegari P.E., et al. An endemic focus of Lyme disease molecular detection of Borrelia burgdorferi DNA in an asymptomatic population . Arthritis Rheum. 36:(suppl):1993;S64.
9. Feder H.M. Jr, Gerber M.A., Krause P.J., et al. A flu-like illness without erythema migrans. Pediatrics. 91:1993;456-459.
10. Steere A.C., Dhar A., Hernandez J., et al. Systemic symptoms without erythema migrans as the presenting picture of early Lyme disease. Am J Med. 114:2003;59-62.
11. Wormser G.P., Nadelman R.B., Nowakowski J., Schwartz I. Asymptomatic Borrelia burgdorferi infection. Med Hypotheses. 57:2001;435-438.
12. Seinost G., Duykhuizen D.E., Dattwyler R.J., et al. Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immun. 67:1999;3518-3524.
13. Sigal L.H., Zahradnik J.M., Lavin P., et al. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. N Engl J Med. 339:1998;216-225.
14. Steere A.C., Sikand V.K., Meurics F., et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N Engl J Med. 339:1998;209-215.
15. Recommendations for test performance and interpretation from the Second International Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep. 44:1995;590-591.
16. Kalish R.A., McHugh G., Granquist J., et al. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. Clin Infect Dis. 33:2001;780-785.
17. Brunner M., Sigal L.H. Immune complexes from Lyme disease sera contain Borrelia burgdorferi antigen and antigen-specific antibodies potential use for improved testing . J Infect Dis. 182:2000;534-539.